Dr. Himmelfarb is currently the Joseph W. Eschbach Endowed Chair for Kidney Research in the Division of Nephrology, Department of Medicine, and the inaugural Director of the Kidney Research Institute at the University of Washington. Dr. Himmelfarb received his medical degree from George Washington University Medical School in 1983 and went to the Maine Medical Center in Portland, Maine for his internship and residency. He completed his Nephrology Fellowship at the Brigham and Women’s Hospital and Maine Medical Center in 1988.
His research interests include the pathophysiology of the disease process that links uremia, inflammation, and malnutrition with cardiovascular complications in uremic patients; oxidative stress and the pro-atherogenic milieu of uremia; the effects of antioxidant therapy on inflammatory biomarkers; cytokine production in acute renal failure; renal replacement therapy, malnutrition and adverse cardiovascular outcomes in uremic patients; anti-inflammatory and antioxidative effects of tocopherols in hemodialysis patients; hemodialysis graft thrombosis; complement and granulocyte activation during hemodialysis; and biocompatible dialysis membranes in acute renal failure. Dr. Himmelfarb has over 154 peer-reviewed publications and currently holds 6 major research grants from the National Institutes
Dr. Jonathan Himmelfarb
